510(k) Report

510(k) · Cleared

Cleared

Sysmex Immature Reticulocyte Fraction (Irf) Parameter

K971736510(k) TraditionalCleared Aug 26, 1997106-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sysmex Corp. · GKZ Counter, Differential Cell

Cleared on Aug 26, 1997 after a 106-day review. The FDA summary names its predicate without a number. 5 later devices descend from it.

Decided
Aug 26, 1997
Review
106 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
0

5 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2000: 1 descendant cleared1999: 1 descendant cleared2002: 1 descendant cleared2005: 1 descendant cleared2015: 1 descendant cleared1995200020052010201520202025
  1. This deviceK971736 Sysmex Immature Reticulocyte Fraction (Irf) ParameterSysmex Corp. · 1997
  2. Descendant · cites it directly · 3 of its ownK991839 Abx Pentra 120 Retic Automated Hematology AnalyzerAbx Diagnostics · 1999
  3. Descendant · 2 generations on · 2 of its ownK022200 Pentra 120/Pentra 120 Retic Options SPS, Model Pentra 120Abx Diagnostics · 2002 · Recalled
  4. Descendant · 2 generations on · 1 of its ownK050719 Abx Pentra DX 120: Option SPS EvolutionHoriba Abx · 2005 · Recalled
  5. Descendant · 2 generations on · 0 of its ownK151133 Pentra XLRHoriba Abx Sas · 2015
  6. Descendant · cites it directly · 0 of its ownK993356 Coulter Hematology Analyzers with Irf & MRV AnalysesCoulter Corp. · 2000

Most influential descendants

Showing 5 of 5 · See all
  • K991839Abx Pentra 120 Retic Automated Hematology AnalyzerAbx Diagnostics · 1999 · cites it directly3descendants
  • K022200Pentra 120/Pentra 120 Retic Options SPS, Model Pentra 120Abx Diagnostics · 2002 · 2 generations on2descendants
  • K050719Abx Pentra DX 120: Option SPS EvolutionHoriba Abx · 2005 · 2 generations on1descendant
  • K151133Pentra XLRHoriba Abx Sas · 2015 · 2 generations on0descendants
  • K993356Coulter Hematology Analyzers with Irf & MRV AnalysesCoulter Corp. · 2000 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K971736Sysmex Immature Reticulocyte Fraction (Irf) ParameterSysmex Corp.1997—
+1K991839Abx Pentra 120 Retic Automated Hematology AnalyzerAbx Diagnostics1999—
+2K022200Pentra 120/Pentra 120 Retic Options SPS, Model Pentra 120Abx Diagnostics20022
+2K050719Abx Pentra DX 120: Option SPS EvolutionHoriba Abx20051
+2K151133Pentra XLRHoriba Abx Sas2015—
+1K993356Coulter Hematology Analyzers with Irf & MRV AnalysesCoulter Corp.2000—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200210
200510
201510
FIG. 1 — Lineage of K971736, 1997–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—reticulocyte count
Named without a submission number
—

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K991839Abx Pentra 120 Retic Automated Hematology AnalyzerAbx Diagnostics19993
K993356Coulter Hematology Analyzers with Irf & MRV AnalysesCoulter Corp.20000

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K991839 (Abx Diagnostics, 1999) has gone furthest, with 3 descendants of its own.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

The IRF parameter of the R-Series analyzers is intended for in-vitro use in clinical laboratories. Its clinical use is to monitor bone marrow suppression and recovery in terms of erythropoiesis in situations of previous cancer chemotherapeutic bone marrow suppression and bone marrow transplantation. Qualified laboratory personnel are responsible for review of all abnormal results.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971736: Sysmex Immature Reticulocyte Fraction (Irf) Parameter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K971736

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026